|
|
||||||||
From the Departments of Clinical Neurosciences (Drs. Hassan, Dong, and Markus, and N. Ali) and Medical Genetics (Dr. Carter), St. Georges Hospital Medical School, London, UK.
Address correspondence and reprint requests to Dr. H.S. Markus, Department of Clinical Neurosciences, St. Georges Hospital Medical School, London, SW17 ORE, UK; e-mail: h.markus{at}sghms.ac.uk
The atrial natriuretic peptide (ANP) gene may underlie stroke susceptibility and sensitivity to cerebral ischemia in an animal model of stroke. The authors investigate its role in humans by genotyping a polymorphism (G664A) in 436 patients with ischemic cerebrovascular disease and 295 community control subjects. The frequency of this variant was similar in both groups and across the different stroke subtypes. The ANP gene G664A polymorphism is therefore unlikely to be an important risk factor for ischemic stroke in this population.
This article has been cited by other articles:
![]() |
J. F. Meschia Addressing the Heterogeneity of the Ischemic Stroke Phenotype in Human Genetics Research Stroke, December 1, 2002; 33(12): 2770 - 2774. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |